Calcitriol plus low dose of alendronate in the treatment of involutional osteoporosis.

被引：0
|
作者：
Nuti, R [1 ]
Martini, G [1 ]
Giovani, S [1 ]
Valenti, R [1 ]
Salvadori, S [1 ]
Silvestri, GM [1 ]
Picchi, A [1 ]
机构：
[1] Univ Siena, Metab Dis Unit, I-53100 Siena, Italy
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA391
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [1] Combined calcitriol-alendronate treatment in osteoporosis.
    Frediani, B
    Porfidio, G
    Bisogno, S
    Ronconi, S
    Corrado, A
    Marcolongo, R
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 632 - 632
  • [2] Effect of Treatment with Calcitriol Combined with Low-Dosage Alendronate in Involutional Osteoporosis
    Ranuccio Nuti
    Giuseppe Martini
    Silvia Giovani
    Roberto Valenti
    Clinical Drug Investigation, 2000, 19 : 55 - 61
  • [3] Effect of treatment with calcitriol combined with low-dosage alendronate in involutional osteoporosis
    Nuti, R
    Martini, G
    Giovani, S
    Valenti, R
    CLINICAL DRUG INVESTIGATION, 2000, 19 (01) : 55 - 61
  • [4] Effect of calcitriol on spinal height in women with involutional osteoporosis.
    Nuti, R
    Martini, G
    Valenti, R
    Giovani, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : S543 - S543
  • [5] Treatment with etidronate or alendronate in postmenopausal osteoporosis.
    Lissens, MA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S277 - S277
  • [6] Alendronate in the prevention of osteoporosis.
    Sambrook, PN
    Rodriguez, JP
    Wasnich, RD
    Luckey, MM
    Kaur, A
    Lombardi, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S207 - S207
  • [7] A comparison of alendronate, cyclical alendronate, etidronate and calcitriol in the treatment of established osteoporosis
    Sahota, O
    Fowler, I
    Blackwell, P
    Masud, T
    Cawte, SA
    San, P
    Hosking, DJ
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S27 - S28
  • [8] A Risk-Benefit Assessment of Alendronate in the Treatment of Involutional Osteoporosis
    Jean-Pierre Devogelaer
    Drug Safety, 1998, 19 : 141 - 154
  • [9] A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis
    Devogelaer, JP
    DRUG SAFETY, 1998, 19 (02) : 141 - 154
  • [10] BONE-TARGETING DELIVERY OF ALENDRONATE FOR THE TREATMENT OF OSTEOPOROSIS.
    Chen, Shen-Mao
    Zhao, Lingling
    Lee, Tung-Chun
    Liu, Chaozong
    TISSUE ENGINEERING PART A, 2022, 28 : S228 - S228
12345